Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis

Transplant International

Volumn 23, Issue 9, 2010, Pages 887-896

  Neurohr, Claus ^a   Huppmann, Patrick ^a   Thum, Dolores ^a   Leuschner, Werner ^a   Von Wulffen, Werner ^a   Meis, Tobias ^a   Leuchte, Hanno ^a   Baumgartner, Rainer ^a   Zimmermann, Gregor ^a   Hatz, Rudolf ^b   Czerner, Stephan ^b   Frey, Lorenz ^b   Ueberfuhr, Peter ^b   Bittmann, Iris ^a   Behr, Juergen ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

idiopathic pulmonary fibrosis; lung transplantation; pulmonary hypertension

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; DEATH; FEMALE; FIBROSING ALVEOLITIS; HUMAN; LUNG ARTERY PRESSURE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

DISEASE-FREE SURVIVAL; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; GERMANY; GRAFT SURVIVAL; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955260345     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01071.x     Document Type: Article

References (29)

1. Christie JD, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report - 2008. J Heart Lung Transplant 2008 27 : 957.
2. Bradley B, Branley HM, Egan JJ, et al. British Thoracic Society Interstitial Lung Disease Guideline Group, British Thoracic Society Standards of Care Committee; Thoracic Society of Australia; New Zealand Thoracic Society; Irish Thoracic Society. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008 63 (Suppl. 5 v1.
3. Thabut G, Mal H, Castier Y, et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003 126 : 469.
4. Orens JB, Estenne M, Arcasoy S, et al. Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update - a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 25 : 745.
5. Hadjiliadis D, Angel LF. Controversies in lung transplantation: are two lungs better than one? Semin Respir Crit Care Med 2006 27 : 561.
6. Meyer DM, Edwards LB, Torres F, Jessen ME, Novick RJ. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 2005 79 : 950.
7. Mason DP, Brizzio ME, Alster JM, et al. Lung transplantation for idiopathic pulmonary fibrosis. Ann Thorac Surg 2007 84 : 1121.
8. Rinaldi M, Sansone F, Boffini M, et al. Single versus double lung transplantation in pulmonary fibrosis: a debated topic. Transplant Proc 2008 40 : 2010.
9. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006 129 : 746.
10. Kuntz CL, Hadjiliadis D, Ahya VN, et al. Risk factors for early primary graft dysfunction after lung transplantation: a registry study. Clin Transplant 2009 23 : 819.
11. Bando K, Keenan RJ, Paradis IL, et al. Impact of pulmonary hypertension on outcome after single-lung transplantation. Ann Thorac Surg 1994 58 : 1336.
12. Whelan TP, Dunitz JM, Kelly RF, et al. Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant 2005 24 : 1269.
13. Meyers BF, Lynch JP, Trulock EP, Guthrie T, Cooper JD, Patterson GA. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: a ten-year institutional experience. J Thorac Cardiovasc Surg 2000 120 : 99.
14. Keating D, Levvey B, Kotsimbos T, et al. Lung transplantation in pulmonary fibrosis: challenging early outcomes counterbalanced by surprisingly good outcomes beyond 15 years. Transplant Proc 2009 41 : 289.
15. American Thoracic Society/European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 2002 165 : 277.
16. American Thoracic Society/European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000 161 (2 Pt. 1 646.
17. Neurohr C, Huppmann P, Zimmermann G, et al. Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation. Transpl Int 2009 22 : 635.
18. Neurohr C, Huppmann P, Samweber B, et al. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients. J Heart Lung Transplant 2009 28 : 468.
19. Estenne M, Maurer JR, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002 21 : 297.
20. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007 26 : 1229.
21. Marsh SG, Albert ED, Bodmer WF, et al. Nomenclature for factors of the HLA system, 2004. Hum Immunol 2005 66 : 571.
22. McEvoy JD, Jones NL. Arterialized capillary blood gases in exercise studies. Med Sci Sports 1975 Winter 7 : 312.
23. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993 16 : 5.
24. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002 166 : 111.
25. Leuchte HH, Neurohr C, Baumgartner R, et al. Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension. Am J Respir Crit Care Med 2004 170 : 360.
26. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008 31 : 1357.
27. Nathan SD, Shlobin OA, Ahmad S, et al. Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 2008 76 : 288.
28. Burton CM, Iversen M, Mortensen J, et al. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder. J Heart Lung Transplant 2007 26 : 1127.
29. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Survival after single versus bilateral lung transplantation for high-risk patients with pulmonary fibrosis. Ann Thorac Surg 2009 88 : 1616.